# Genomically Guided Radiation Therapy in the Management of Triple Negative Breast Cancer

> **NCT05528133** · PHASE2 · RECRUITING · sponsor: **H. Lee Moffitt Cancer Center and Research Institute** · enrollment: 86 (estimated)

## Conditions studied

- Triple Negative Breast Cancer

## Interventions

- **RADIATION:** Genomically Guided Radiation Therapy
- **RADIATION:** Genomically Guided Radiation Therapy

## Key facts

- **NCT ID:** NCT05528133
- **Lead sponsor:** H. Lee Moffitt Cancer Center and Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-01-25
- **Primary completion:** 2028-05
- **Final completion:** 2028-05
- **Target enrollment:** 86 (ESTIMATED)
- **Last updated:** 2026-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05528133

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05528133, "Genomically Guided Radiation Therapy in the Management of Triple Negative Breast Cancer". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05528133. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*